Review




Structured Review

ABclonal Biotechnology rabbit anti-mouse antibodies against jnk
Rabbit Anti Mouse Antibodies Against Jnk, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-mouse antibodies against jnk/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti-mouse antibodies against jnk - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

90
ABclonal Biotechnology rabbit anti-mouse antibodies against jnk
Rabbit Anti Mouse Antibodies Against Jnk, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-mouse antibodies against jnk/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti-mouse antibodies against jnk - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc mouse monoclonal antibody against jnk
Mouse Monoclonal Antibody Against Jnk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibody against jnk/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
mouse monoclonal antibody against jnk - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc rabbit igg against total jnk α tjnk
Dab2 reduces <t>JNK</t> activation by TGF-β. (A) Knockdown of Dab2 enhances TGF-β–mediated JNK/c-Jun activation. ES-2 cells were transfected with siRNA (nontargeting or directed against Dab2). At 48 h posttransfection, the cells were serum starved (30 min), stimulated (or not) with 100 pM TGF-β1 (30 or 120 min), and analyzed (see Materials and Methods ) by immunoblotting for p-JNK, t-JNK pc-Jun, tc-Jun, pSmad2/3, tSmad2/3, and β-actin. (B) Stable expression of Dab2 abrogates JNK activation. ES-2 and ES-2-Dab2 cells were activated by TGF-β1 (for 30 or 60 min) and analyzed by Western blotting as in A. (C) Quantification of JNK phosphorylation in cells expressing different Dab2 levels (as shown in A and B). Cells transfected with siDab2 demonstrate significantly higher level of <t>pJNK/tJNK</t> ratio compared with ES-2 or ES-2-Dab2 cells. Each bar is the mean ± SEM of three independent experiments (** p < 0.01). (D) Transient overexpression of Dab2 prevents TGF-β stimulation of JNK/c-Jun. Caov3 cells were transfected with GFP (control) or GFP-Dab2. At 24 h posttransfection, the cells were serum starved (60 min), stimulated (or not) with 100 pM TGF-β1 (30 or 60 min), and analyzed as described. All blots shown are of representative experiments ( n = 3 in each case).
Rabbit Igg Against Total Jnk α Tjnk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit igg against total jnk α tjnk/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
rabbit igg against total jnk α tjnk - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc mouse monoclonal antibody against p jnk
Dab2 reduces <t>JNK</t> activation by TGF-β. (A) Knockdown of Dab2 enhances TGF-β–mediated JNK/c-Jun activation. ES-2 cells were transfected with siRNA (nontargeting or directed against Dab2). At 48 h posttransfection, the cells were serum starved (30 min), stimulated (or not) with 100 pM TGF-β1 (30 or 120 min), and analyzed (see Materials and Methods ) by immunoblotting for p-JNK, t-JNK pc-Jun, tc-Jun, pSmad2/3, tSmad2/3, and β-actin. (B) Stable expression of Dab2 abrogates JNK activation. ES-2 and ES-2-Dab2 cells were activated by TGF-β1 (for 30 or 60 min) and analyzed by Western blotting as in A. (C) Quantification of JNK phosphorylation in cells expressing different Dab2 levels (as shown in A and B). Cells transfected with siDab2 demonstrate significantly higher level of <t>pJNK/tJNK</t> ratio compared with ES-2 or ES-2-Dab2 cells. Each bar is the mean ± SEM of three independent experiments (** p < 0.01). (D) Transient overexpression of Dab2 prevents TGF-β stimulation of JNK/c-Jun. Caov3 cells were transfected with GFP (control) or GFP-Dab2. At 24 h posttransfection, the cells were serum starved (60 min), stimulated (or not) with 100 pM TGF-β1 (30 or 60 min), and analyzed as described. All blots shown are of representative experiments ( n = 3 in each case).
Mouse Monoclonal Antibody Against P Jnk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibody against p jnk/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
mouse monoclonal antibody against p jnk - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology rabbit polyclonal antibodies against total jnk
Dab2 reduces <t>JNK</t> activation by TGF-β. (A) Knockdown of Dab2 enhances TGF-β–mediated JNK/c-Jun activation. ES-2 cells were transfected with siRNA (nontargeting or directed against Dab2). At 48 h posttransfection, the cells were serum starved (30 min), stimulated (or not) with 100 pM TGF-β1 (30 or 120 min), and analyzed (see Materials and Methods ) by immunoblotting for p-JNK, t-JNK pc-Jun, tc-Jun, pSmad2/3, tSmad2/3, and β-actin. (B) Stable expression of Dab2 abrogates JNK activation. ES-2 and ES-2-Dab2 cells were activated by TGF-β1 (for 30 or 60 min) and analyzed by Western blotting as in A. (C) Quantification of JNK phosphorylation in cells expressing different Dab2 levels (as shown in A and B). Cells transfected with siDab2 demonstrate significantly higher level of <t>pJNK/tJNK</t> ratio compared with ES-2 or ES-2-Dab2 cells. Each bar is the mean ± SEM of three independent experiments (** p < 0.01). (D) Transient overexpression of Dab2 prevents TGF-β stimulation of JNK/c-Jun. Caov3 cells were transfected with GFP (control) or GFP-Dab2. At 24 h posttransfection, the cells were serum starved (60 min), stimulated (or not) with 100 pM TGF-β1 (30 or 60 min), and analyzed as described. All blots shown are of representative experiments ( n = 3 in each case).
Rabbit Polyclonal Antibodies Against Total Jnk, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibodies against total jnk/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
rabbit polyclonal antibodies against total jnk - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc materials mouse monoclonal antibodies against active phosphorylated jnk
FIG. 3. Nck1 is involved in ETA receptor-induced <t>JNK</t> activa- tion. JNK activity (A–C, E, and F) and ERK activity (D) were measured as described under ‘‘Experimental Procedures.’’ Cells co-transfected with the ETA receptor (A–C) and dominant negative mutants of Nck1 (A), Grb2 (B), or CrkII (C) were treated with ET-1 (100 nM, 20 min). Endogenous JNK was immunoprecipitated with anti-JNK antibody and blotted with <t>anti-phosphorylated</t> JNK antibody or anti-JNK antibody. The levels of JNK phosphorylation were quantified and normalized against the total immunoprecipitated JNK levels. D–F, cells transfected with the dominant negative mutants of adaptor proteins were treated with EGF (10 ng/ml, 10 min). The cell lysates were blotted with an anti-phosphorylated ERK or anti-ERK antibody. The levels of ERK or JNK phosphorylation were quantified and normalized against the total immunoprecipitated ERK or JNK levels. Expression of the ETA recep- tor (A–C) and the dominant negative mutants of adaptor proteins (A–F) is shown.
Materials Mouse Monoclonal Antibodies Against Active Phosphorylated Jnk, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/materials mouse monoclonal antibodies against active phosphorylated jnk/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
materials mouse monoclonal antibodies against active phosphorylated jnk - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

Image Search Results


Dab2 reduces JNK activation by TGF-β. (A) Knockdown of Dab2 enhances TGF-β–mediated JNK/c-Jun activation. ES-2 cells were transfected with siRNA (nontargeting or directed against Dab2). At 48 h posttransfection, the cells were serum starved (30 min), stimulated (or not) with 100 pM TGF-β1 (30 or 120 min), and analyzed (see Materials and Methods ) by immunoblotting for p-JNK, t-JNK pc-Jun, tc-Jun, pSmad2/3, tSmad2/3, and β-actin. (B) Stable expression of Dab2 abrogates JNK activation. ES-2 and ES-2-Dab2 cells were activated by TGF-β1 (for 30 or 60 min) and analyzed by Western blotting as in A. (C) Quantification of JNK phosphorylation in cells expressing different Dab2 levels (as shown in A and B). Cells transfected with siDab2 demonstrate significantly higher level of pJNK/tJNK ratio compared with ES-2 or ES-2-Dab2 cells. Each bar is the mean ± SEM of three independent experiments (** p < 0.01). (D) Transient overexpression of Dab2 prevents TGF-β stimulation of JNK/c-Jun. Caov3 cells were transfected with GFP (control) or GFP-Dab2. At 24 h posttransfection, the cells were serum starved (60 min), stimulated (or not) with 100 pM TGF-β1 (30 or 60 min), and analyzed as described. All blots shown are of representative experiments ( n = 3 in each case).

Journal: Molecular Biology of the Cell

Article Title: Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β

doi: 10.1091/mbc.E13-09-0537

Figure Lengend Snippet: Dab2 reduces JNK activation by TGF-β. (A) Knockdown of Dab2 enhances TGF-β–mediated JNK/c-Jun activation. ES-2 cells were transfected with siRNA (nontargeting or directed against Dab2). At 48 h posttransfection, the cells were serum starved (30 min), stimulated (or not) with 100 pM TGF-β1 (30 or 120 min), and analyzed (see Materials and Methods ) by immunoblotting for p-JNK, t-JNK pc-Jun, tc-Jun, pSmad2/3, tSmad2/3, and β-actin. (B) Stable expression of Dab2 abrogates JNK activation. ES-2 and ES-2-Dab2 cells were activated by TGF-β1 (for 30 or 60 min) and analyzed by Western blotting as in A. (C) Quantification of JNK phosphorylation in cells expressing different Dab2 levels (as shown in A and B). Cells transfected with siDab2 demonstrate significantly higher level of pJNK/tJNK ratio compared with ES-2 or ES-2-Dab2 cells. Each bar is the mean ± SEM of three independent experiments (** p < 0.01). (D) Transient overexpression of Dab2 prevents TGF-β stimulation of JNK/c-Jun. Caov3 cells were transfected with GFP (control) or GFP-Dab2. At 24 h posttransfection, the cells were serum starved (60 min), stimulated (or not) with 100 pM TGF-β1 (30 or 60 min), and analyzed as described. All blots shown are of representative experiments ( n = 3 in each case).

Article Snippet: Rabbit IgG against total JNK (α-tJNK), phospho-JNK (α-pJNK), phospho-c-Jun (pc-Jun), and mouse anti–total c-Jun (α-tc-Jun) were from Cell Signaling (Beverly, MA).

Techniques: Activation Assay, Knockdown, Transfection, Western Blot, Expressing, Phospho-proteomics, Over Expression, Control

JNK phosphorylation does not require TβRI kinase activity. ES-2 cells were transfected with siRNA (siControl or siDab2). At 48 h posttransfection, the cells were left untreated or treated with SB431542 (10 μM, 1 h), stimulated (or not) with 100 pM TGF-β1 (30 min), and analyzed (see Materials and Methods ) by immunoblotting for pJNK, tJNK, pc-Jun, tc-Jun, pSmad2/3, and tSmad2/3. The blot shown is of a representative experiment ( n = 3). No significant differences in the fold increase of pJNK/tJNK or of pc-Jun/tc-Jun after TGF-β stimulation were observed between untreated and SB431542-treated cells.

Journal: Molecular Biology of the Cell

Article Title: Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β

doi: 10.1091/mbc.E13-09-0537

Figure Lengend Snippet: JNK phosphorylation does not require TβRI kinase activity. ES-2 cells were transfected with siRNA (siControl or siDab2). At 48 h posttransfection, the cells were left untreated or treated with SB431542 (10 μM, 1 h), stimulated (or not) with 100 pM TGF-β1 (30 min), and analyzed (see Materials and Methods ) by immunoblotting for pJNK, tJNK, pc-Jun, tc-Jun, pSmad2/3, and tSmad2/3. The blot shown is of a representative experiment ( n = 3). No significant differences in the fold increase of pJNK/tJNK or of pc-Jun/tc-Jun after TGF-β stimulation were observed between untreated and SB431542-treated cells.

Article Snippet: Rabbit IgG against total JNK (α-tJNK), phospho-JNK (α-pJNK), phospho-c-Jun (pc-Jun), and mouse anti–total c-Jun (α-tc-Jun) were from Cell Signaling (Beverly, MA).

Techniques: Phospho-proteomics, Activity Assay, Transfection, Western Blot

TGF-β-stimulated JNK phosphorylation is cholesterol dependent. ES-2 cells were transfected with siRNA (siControl or siDab2). At 36 h posttransfection, cells were subjected (or not) to metabolic cholesterol depletion (CD; 12 h). Alternatively, cells at 48 h posttransfection were left untreated or treated with nystatin (25 μg/ml, 2 h). In both experimental conditions, cells were then stimulated (or not) with 100 pM TGF-β1 (30 min), and analyzed (see Materials and Methods ) by immunoblotting for Dab2, pJNK, tJNK, pSmad2/3, and tSmad2/3. The blot shown is of a representative experiment ( n = 3). Although the pJNK/tJNK ratio significantly increased in untreated siDab2 cells after stimulation with TGF-β ( p < 0.05), no significant increase was observed in these cells after treatment with nystatin or cholesterol depletion.

Journal: Molecular Biology of the Cell

Article Title: Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β

doi: 10.1091/mbc.E13-09-0537

Figure Lengend Snippet: TGF-β-stimulated JNK phosphorylation is cholesterol dependent. ES-2 cells were transfected with siRNA (siControl or siDab2). At 36 h posttransfection, cells were subjected (or not) to metabolic cholesterol depletion (CD; 12 h). Alternatively, cells at 48 h posttransfection were left untreated or treated with nystatin (25 μg/ml, 2 h). In both experimental conditions, cells were then stimulated (or not) with 100 pM TGF-β1 (30 min), and analyzed (see Materials and Methods ) by immunoblotting for Dab2, pJNK, tJNK, pSmad2/3, and tSmad2/3. The blot shown is of a representative experiment ( n = 3). Although the pJNK/tJNK ratio significantly increased in untreated siDab2 cells after stimulation with TGF-β ( p < 0.05), no significant increase was observed in these cells after treatment with nystatin or cholesterol depletion.

Article Snippet: Rabbit IgG against total JNK (α-tJNK), phospho-JNK (α-pJNK), phospho-c-Jun (pc-Jun), and mouse anti–total c-Jun (α-tc-Jun) were from Cell Signaling (Beverly, MA).

Techniques: Phospho-proteomics, Transfection, Western Blot

FIG. 3. Nck1 is involved in ETA receptor-induced JNK activa- tion. JNK activity (A–C, E, and F) and ERK activity (D) were measured as described under ‘‘Experimental Procedures.’’ Cells co-transfected with the ETA receptor (A–C) and dominant negative mutants of Nck1 (A), Grb2 (B), or CrkII (C) were treated with ET-1 (100 nM, 20 min). Endogenous JNK was immunoprecipitated with anti-JNK antibody and blotted with anti-phosphorylated JNK antibody or anti-JNK antibody. The levels of JNK phosphorylation were quantified and normalized against the total immunoprecipitated JNK levels. D–F, cells transfected with the dominant negative mutants of adaptor proteins were treated with EGF (10 ng/ml, 10 min). The cell lysates were blotted with an anti-phosphorylated ERK or anti-ERK antibody. The levels of ERK or JNK phosphorylation were quantified and normalized against the total immunoprecipitated ERK or JNK levels. Expression of the ETA recep- tor (A–C) and the dominant negative mutants of adaptor proteins (A–F) is shown.

Journal: Journal of Biological Chemistry

Article Title: The Adaptor Protein Nck1 Mediates Endothelin A Receptor-regulated Cell Migration through the Cdc42-dependent c-Jun N-terminal Kinase Pathway

doi: 10.1074/jbc.m402767200

Figure Lengend Snippet: FIG. 3. Nck1 is involved in ETA receptor-induced JNK activa- tion. JNK activity (A–C, E, and F) and ERK activity (D) were measured as described under ‘‘Experimental Procedures.’’ Cells co-transfected with the ETA receptor (A–C) and dominant negative mutants of Nck1 (A), Grb2 (B), or CrkII (C) were treated with ET-1 (100 nM, 20 min). Endogenous JNK was immunoprecipitated with anti-JNK antibody and blotted with anti-phosphorylated JNK antibody or anti-JNK antibody. The levels of JNK phosphorylation were quantified and normalized against the total immunoprecipitated JNK levels. D–F, cells transfected with the dominant negative mutants of adaptor proteins were treated with EGF (10 ng/ml, 10 min). The cell lysates were blotted with an anti-phosphorylated ERK or anti-ERK antibody. The levels of ERK or JNK phosphorylation were quantified and normalized against the total immunoprecipitated ERK or JNK levels. Expression of the ETA recep- tor (A–C) and the dominant negative mutants of adaptor proteins (A–F) is shown.

Article Snippet: Materials—Mouse monoclonal antibodies against active phosphorylated JNK (Thr183/Tyr185), active phosphorylated ERK (Thr202/Tyr204), and rabbit polyclonal antibodies against JNK and ERK were purchased from Cell Signaling Technology, Inc (Beverly, MA).

Techniques: Activity Assay, Transfection, Dominant Negative Mutation, Immunoprecipitation, Phospho-proteomics, Expressing

FIG. 6. Effects of siNck1 on the ETA receptor-induced inhibi- tion of cell migration and Cdc42/JNK activation. A, sequence of the synthetic siRNA duplex targeting Nck1 (siNck1–1 or siNck1–2). The 2-nucleotide 3 overhang of 2-deoxythymidine is indicated as TT. The indicated amount of siRNAs was transfected using LipofectAMINE 2000 into the cells. The cell lysates were immunoblotted with anti-Nck1 or anti-tubulin antibodies. B, cells were transfected with siNck1–1 or siGFP using LipofectAMINE 2000. The phosphorylated JNK was de- tected after the addition of ET-1. C, cells were transfected with siNck1–1 or siGFP. After incubation with ET-1, the migrating cells in the Boyden chambers were stained and counted. Data were evaluated using the Student’s t test. Asterisks indicate p 0.01.

Journal: Journal of Biological Chemistry

Article Title: The Adaptor Protein Nck1 Mediates Endothelin A Receptor-regulated Cell Migration through the Cdc42-dependent c-Jun N-terminal Kinase Pathway

doi: 10.1074/jbc.m402767200

Figure Lengend Snippet: FIG. 6. Effects of siNck1 on the ETA receptor-induced inhibi- tion of cell migration and Cdc42/JNK activation. A, sequence of the synthetic siRNA duplex targeting Nck1 (siNck1–1 or siNck1–2). The 2-nucleotide 3 overhang of 2-deoxythymidine is indicated as TT. The indicated amount of siRNAs was transfected using LipofectAMINE 2000 into the cells. The cell lysates were immunoblotted with anti-Nck1 or anti-tubulin antibodies. B, cells were transfected with siNck1–1 or siGFP using LipofectAMINE 2000. The phosphorylated JNK was de- tected after the addition of ET-1. C, cells were transfected with siNck1–1 or siGFP. After incubation with ET-1, the migrating cells in the Boyden chambers were stained and counted. Data were evaluated using the Student’s t test. Asterisks indicate p 0.01.

Article Snippet: Materials—Mouse monoclonal antibodies against active phosphorylated JNK (Thr183/Tyr185), active phosphorylated ERK (Thr202/Tyr204), and rabbit polyclonal antibodies against JNK and ERK were purchased from Cell Signaling Technology, Inc (Beverly, MA).

Techniques: Migration, Activation Assay, Sequencing, Transfection, Incubation, Staining

FIG. 7. The Src kinase-induced inhibition of cell migration and activation of JNK involves Nck1. Cells were co-transfected with CA-Src and dominant negative mutants of Nck1. After incubation for 5 h, the cells attached to the filters were stained and counted (A). The phosphorylated JNK was analyzed 20 min after stimulation with ET-1 (B). Expression of CA-Src and the dominant negative mutants of Nck1 is shown.

Journal: Journal of Biological Chemistry

Article Title: The Adaptor Protein Nck1 Mediates Endothelin A Receptor-regulated Cell Migration through the Cdc42-dependent c-Jun N-terminal Kinase Pathway

doi: 10.1074/jbc.m402767200

Figure Lengend Snippet: FIG. 7. The Src kinase-induced inhibition of cell migration and activation of JNK involves Nck1. Cells were co-transfected with CA-Src and dominant negative mutants of Nck1. After incubation for 5 h, the cells attached to the filters were stained and counted (A). The phosphorylated JNK was analyzed 20 min after stimulation with ET-1 (B). Expression of CA-Src and the dominant negative mutants of Nck1 is shown.

Article Snippet: Materials—Mouse monoclonal antibodies against active phosphorylated JNK (Thr183/Tyr185), active phosphorylated ERK (Thr202/Tyr204), and rabbit polyclonal antibodies against JNK and ERK were purchased from Cell Signaling Technology, Inc (Beverly, MA).

Techniques: Inhibition, Migration, Activation Assay, Transfection, Dominant Negative Mutation, Incubation, Staining, Expressing